Detalles de la búsqueda
1.
PD-1 inhibitor combined with albumin paclitaxel and apatinib as second-line treatment for patients with metastatic gastric cancer: a single-center, single-arm, phase II study.
Invest New Drugs
; 42(2): 171-178, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347177
2.
Efficacy and safety of apatinib as second-line therapy for advanced gastric cancer: a single-center observational study.
Anticancer Drugs
; 29(2): 184-189, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29215372
3.
PD-1 inhibitors-based second-line therapy for metastatic gastric cancer.
Front Immunol
; 14: 1136437, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37304303
4.
Prognostic value of the Lung Immune Prognostic Index for HER-2-negative metastatic gastric cancer.
Biomark Med
; 17(17): 711-721, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085163
5.
Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy.
Discov Oncol
; 13(1): 118, 2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326905
6.
Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China.
Front Oncol
; 12: 851756, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35875064
7.
Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy.
Front Immunol
; 13: 950868, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36225924
8.
A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.
Front Oncol
; 12: 951985, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387152
9.
Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score.
J Oncol
; 2022: 1427779, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35342416
10.
Research on Mechanism of miR-214 Packaged with Lipidosome Nanoparticles on Prompting the Apoptosis of Intestinal Cancer Through Regulating p53 Pathway.
J Biomed Nanotechnol
; 17(12): 2391-2398, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34974862
11.
Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer.
J Immunol Res
; 2021: 2549295, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34993252
12.
The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy.
Front Oncol
; 11: 655716, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211839
13.
PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis.
Front Oncol
; 11: 648068, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34221968
14.
Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer.
Dis Markers
; 2021: 6639366, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34239621
15.
Divergent expression of DCLK1 in gastrointestinal neuroendocrine tumors and primary hepatic, gallbladder, and pancreatic neuroendocrine tumors.
Int J Clin Exp Pathol
; 13(9): 2249-2258, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33042329
16.
LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4.
Biomed Pharmacother
; 125: 109916, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062383
17.
Efficacy and safety of nivolumab for metastatic biliary tract cancer.
Onco Targets Ther
; 12: 861-867, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30774373
18.
The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer.
Dis Markers
; 2019: 6812045, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30805037
19.
Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study.
Sci Rep
; 8(1): 4602, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545575
20.
CD19loCD27hi Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal Cancer.
DNA Cell Biol
; 36(10): 870-877, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28829194